HR Execs on the Move

ProSomnus

www.prosomnus.com

 
ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.prosomnus.com
  • 5675 Gibraltar Drive
    Pleasanton, CA USA 94588
  • Phone: 844.537.5337

Executives

Name Title Contact Details
Brian Dow
 Chief Financial Officer Profile

Similar Companies

KMR Medical

KMR Medical is a Provo, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kreg Therapeutics

Kreg Therapeutics is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

U-Metco

U-Metco is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Via Biomedical

Via Biomedical, Inc is a Osseo, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

IlluminOss

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Flare Capital Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology.